How to Get a Norwich Pharmacal Order in Mauritius (bank Disclosure, Costs & Timelines)

Understanding how to get a Norwich Pharmacal order is now essential for any practitioner pursuing asset recovery or fraud claims through Mauritius-based banks. The Judicial Committee of the Privy Council’s landmark decision in Stanford Asset Holdings Ltd & Anor v AfrAsia Bank Ltd [2023] UKPC 35 confirmed that Mauritius courts possess the jurisdiction to grant Norwich Pharmacal disclosure against banks, notwithstanding section 64 of the Banking Act 2004. This guide provides a step-by-step procedural playbook, covering evidence requirements, application procedure, likely bank objections, costs, and realistic timelines, tailored specifically to the Norwich Pharmacal order Mauritius framework as it stands in 2026.

Whether the objective is to identify an unknown wrongdoer, trace misappropriated funds, or secure evidence for parallel proceedings abroad, claimant’s counsel will find actionable guidance throughout.

Quick Answer & TL;DR, What This Guide Covers

Applicants can obtain a Norwich Pharmacal order against a Mauritius bank. The Privy Council has settled the jurisdictional question: section 64 of the Banking Act 2004 does not oust the court’s inherent equitable power to order disclosure. The practical steps are straightforward once the evidential threshold is met.

Key takeaways:

• Jurisdiction confirmed. Stanford Asset Holdings v AfrAsia [2023] UKPC 35 established that Norwich Pharmacal relief is available in Mauritius, even against banks invoking statutory confidentiality.
• Seek preservation first. Before filing, consider urgent freezing or preservation measures to prevent dissipation of evidence or funds.
• Prepare a complete application bundle. Witness statements, a chronology, proposed draft order with protective measures, and a privacy impact assessment should all be assembled before approaching the Supreme Court.
• Anticipate bank objections. Respondent banks routinely raise section 64, Data Protection Act 2017 obligations, and proportionality, each can be addressed with proper protective proposals.
• Timelines vary. Urgent ex parte applications can be heard within 7–21 days; standard contested applications typically take 4–12 weeks.

Legal Background, Norwich Pharmacal Jurisdiction in Mauritius (Privy Council Update)

The Norwich Pharmacal order traces its origins to the House of Lords decision in Norwich Pharmacal Co v Customs and Excise Commissioners [1974] AC 133. The principle is that where a person, through no fault of their own, becomes mixed up in the tortious or wrongful acts of another so as to facilitate those acts, that person comes under a duty to assist the injured party by providing information and disclosure necessary to pursue the wrongdoer.

For decades, the availability of this remedy in Mauritius was clouded by the banking secrecy laws in Mauritius, principally section 64 of the Banking Act 2004, which imposes a broad duty of confidentiality on banks and their employees regarding customer information. Banks frequently argued that this statutory duty barred any court-ordered disclosure.

The Privy Council Norwich Pharmacal Mauritius position was decisively clarified in Stanford Asset Holdings Ltd & Anor v AfrAsia Bank Ltd [2023] UKPC 35. The JCPC held that section 64 does not oust the court’s inherent equitable jurisdiction to grant Norwich Pharmacal orders. The Board reasoned that the duty of confidentiality under section 64 is common-law and equitable in character, subject to exceptions, including the recognised exception permitting disclosure under compulsion of law. Section 64(3)(d) of the Banking Act 2004 itself contemplates disclosure in civil proceedings involving a bank and its customer, further supporting the court’s power.

Additionally, the Data Protection Act 2017 must be considered wherever personal data is involved, requiring applicants to propose adequate protective measures as part of any disclosure order.

Key Legislative and Judicial Timeline

When to Apply, Legal Tests and Strategic Timing for How to Get a Norwich Order

The established criteria for a Norwich Pharmacal order, as confirmed by the Privy Council and applicable in Mauritius, require the applicant to demonstrate each of the following elements:

• Good arguable case of wrongdoing. The applicant must show a credible, arguable claim that a wrong has been committed, not merely suspicion, but evidence sufficient to cross the threshold of a prima facie case.
• Respondent is mixed up in or facilitates the wrongdoing. The bank or third party need not itself be a wrongdoer. It is enough that the respondent is innocently “mixed up” in the relevant transactions and possesses the information sought.
• Necessity and proportionality. Disclosure must be necessary to enable the applicant to pursue legitimate proceedings and must be proportionate to the objectives sought, the court will not sanction a fishing expedition.
• Proper purpose. The application must not be brought for collateral or improper motives. Industry observers expect courts to scrutinise this criterion carefully where there are parallel regulatory or criminal investigations.

Strategically, applicants face two procedural routes. The first is to commence substantive proceedings (e.g., a fraud or tracing claim) and seek the Norwich Pharmacal order as interlocutory relief within those proceedings. The second is to bring a standalone application against the third-party bank, prior to or independently of substantive proceedings. Both routes are available in Mauritius practice, and the choice often depends on urgency and whether the identity of the primary wrongdoer is known.

Where funds are at risk of dissipation, counsel should consider coupling the Norwich Pharmacal application with urgent preservation or freezing measures. Equally, if a criminal investigation is underway, early liaison with the Financial Intelligence Unit is advisable to avoid conflicts and ensure that court-ordered disclosure does not prejudice parallel proceedings.

Evidence & Drafting, What to Include in the Application Bundle

The strength of a Norwich Pharmacal application rests on the quality of the supporting evidence. Incomplete or poorly drafted bundles invite delay, contested hearings, and adverse cost consequences. The criteria for a Norwich Pharmacal order demand that each element, arguable wrong, respondent involvement, necessity, proportionality, and proper purpose, is evidenced on affidavit.

Sample Evidence Checklist

Drafting Tips for Witness Statements

Witness statements should follow a strict narrative structure: background, identification of the wrongdoing, evidence of the respondent’s involvement, explanation of why disclosure is necessary, and confirmation that no alternative source of the information exists. Each factual assertion should be supported by a referenced exhibit. Counsel should resist the temptation to over-plead, the affidavit must demonstrate a good arguable case without straying into detailed merits arguments that belong in substantive proceedings.

Protective Measures, Confidentiality Ring, Redaction, Limited Disclosure

Given the banking secrecy laws in Mauritius and the Data Protection Act 2017, the application should always propose protective measures. These typically include:

• Confidentiality ring. Only named individuals (counsel, instructing solicitor, and the applicant’s nominated representative) may access the disclosed material.
• Redaction of third-party data. Information relating to account holders who are not connected to the wrongdoing should be redacted before production.
• Sealed court schedules. Sensitive schedules annexed to the order can be sealed, preventing public inspection.
• Limited-purpose undertakings. The applicant undertakes to use disclosed material only for the stated proceedings and not for any collateral purpose.

How to Get a Norwich Pharmacal Order, Step-by-Step Procedure for Filing, Forms, Service, and Sample Orders

The following procedural playbook sets out how to get a Norwich Pharmacal order in Mauritius from pre-action through to bank compliance.

Step 1, Pre-action preservation. If there is a risk of dissipation, seek urgent freezing or preservation relief before filing the Norwich Pharmacal application. This may involve an ex parte approach to the Judge in Chambers.

Step 2, Assemble the application bundle. Prepare the witness statement, exhibits, chronology, proposed draft order, and privacy impact assessment as detailed above.

Step 3, File the application with the Supreme Court. The application is made to the Supreme Court of Mauritius. Where the identity of the wrongdoer is unknown and no substantive proceedings have been commenced, a standalone application is filed. The form of application should identify the respondent bank and the categories of information sought.

Step 4, Choose between with-notice and without-notice proceedings. In urgent cases, or where there is a genuine risk that the respondent or the wrongdoer will destroy evidence, an ex parte (without-notice) application is appropriate. Otherwise, the bank should be served and given the opportunity to respond.

Step 5, Serve the application on the bank (and, where appropriate, the regulator). Service on the respondent bank should be effected in accordance with Supreme Court rules. Where the Financial Intelligence Unit or the Bank of Mauritius should be notified, liaison letters should be sent simultaneously.

Step 6, Attend the hearing. Present the evidence and submit the proposed draft order. Be prepared to address proportionality, necessity, and the adequacy of protective measures. The court will assess whether the criteria are met and whether the order should be made in the terms proposed.

Step 7, Bank compliance. Once the order is made, the bank will be given a specified period to comply, typically 7–28 days for urgent orders, or longer for complex disclosure. Compliance usually takes the form of a sworn affidavit accompanied by the documents ordered.

Draft Sample Norwich Pharmacal Order, Key Clauses

A well-drafted proposed order should contain the following core provisions (adapted to the facts of each case):

“IT IS ORDERED that the Respondent [Bank Name] do, within [14/21/28] days of service of this Order, disclose to the Applicant by way of affidavit: (a) the identity of the holder(s) of Account No. [X] maintained at the Respondent; (b) copies of all account opening documentation; (c) copies of all statements of account and SWIFT messages relating to transactions credited to or debited from the said account during the period [date] to [date]; (d) any further information in the Respondent’s possession identifying the source and destination of funds passing through the said account.”

“IT IS FURTHER ORDERED that the information disclosed pursuant to this Order shall be subject to a confidentiality ring limited to [names] and shall not be used for any purpose other than these proceedings and any substantive proceedings arising therefrom, without further leave of the Court.”

Practical Timeline, Urgent vs Standard Applications

Comparison: Norwich Pharmacal vs Bankers Trust vs Statutory Disclosure

Likely Bank Responses & Statutory Protections, Banking Secrecy Laws in Mauritius

Respondent banks in Mauritius routinely raise a set of standard objections when served with a Norwich Pharmacal application. Claimant’s counsel should be prepared with tactical responses to each.

• Section 64 Banking Act 2004, duty of confidentiality. This is the primary defence. However, following Stanford Asset Holdings v AfrAsia [2023] UKPC 35, the Privy Council held that section 64 does not oust the court’s Norwich Pharmacal jurisdiction. The Board reasoned that the statutory duty of confidentiality is subject to the recognised common-law exception of disclosure compelled by court order. Section 64(3)(d) expressly contemplates disclosure in civil proceedings. The tactical response is to cite the JCPC authority directly and demonstrate that the proposed order includes adequate protective measures.
• Data Protection Act 2017 concerns. Banks may argue that producing customer data violates data protection obligations. The response is to present the privacy impact assessment prepared as part of the application bundle and to propose redaction, confidentiality rings, and limited-use undertakings, all of which the court has the power to impose.
• “Mere witness” objection. Some banks contend they are mere witnesses and not “mixed up” in any wrongdoing. The correct position is that a bank through which wrongfully obtained funds have passed is, by definition, mixed up in the facilitation of the wrong, even innocently, and therefore falls within the Norwich Pharmacal principle.
• Proportionality and fishing. Banks may assert that the disclosure sought is disproportionate or amounts to a fishing expedition. The response lies in tightly defining the categories of documents sought, confining the relevant period, and demonstrating genuine necessity. A well-drafted proposed order addresses this objection on its face.

The likely practical effect of the 2023 Privy Council decision will be that banks increasingly focus their objections on the scope and proportionality of disclosure rather than on jurisdiction, since the jurisdictional argument is now settled.

Costs, Recoverability & Timelines, What to Expect in 2026

Applicants should budget carefully for a Norwich Pharmacal application. The cost structure comprises several components, and recoverability is at the court’s discretion.

• Court filing fees. Supreme Court filing fees in Mauritius are relatively modest compared to international centres.
• Counsel fees. These vary considerably depending on complexity and urgency. As a general guide: junior local counsel with solicitor support represents the entry-level band; mid-range matters involving contested hearings and bank opposition sit in a higher band; full urgent applications with senior counsel, expert forensic tracing, and multi-jurisdictional coordination occupy the premium band.
• Expert and forensic costs. Where SWIFT tracing or forensic accounting is needed to support the evidence bundle, these costs should be budgeted separately.
• Expedited hearing premium. Urgent ex parte hearings may involve additional preparation costs and counsel availability premiums.

Cost recovery. In Mauritius, the award of costs is discretionary. Early indications suggest that where the applicant succeeds and the bank has raised unreasonable objections, a favourable costs order is achievable. However, the conventional position is that the applicant bears the respondent’s reasonable costs of complying with the order, a principle established in the original Norwich Pharmacal case. Counsel should consider seeking a protective costs order at the outset if the overall value of the claim justifies the expense.

Budgetary checklist: Confirm scope of disclosure (narrow = lower cost); estimate number of hearing days; assess whether forensic experts are needed; confirm whether the application is contested or on notice; and factor in the respondent’s compliance costs (which the applicant typically bears).

Practical Checklist & Templates Before Filing a Norwich Pharmacal Order Mauritius Application

The following 20-step checklist guides counsel from initial instructions through to the filing of a Norwich Pharmacal application in Mauritius:

1. Obtain detailed client instructions, including the nature of the wrongdoing and the evidence available.
2. Identify the respondent bank(s) and the specific accounts or transactions at issue.
3. Assess whether urgent preservation or freezing measures are required before filing.
4. Conduct a conflict check and confirm that there are no parallel criminal proceedings that might complicate disclosure.
5. Prepare a detailed chronology of relevant events and transactions.
6. Draft the applicant’s witness statement in strict narrative form, with referenced exhibits.
7. Obtain and exhibit all available SWIFT traces, bank statements, and transaction records.
8. Prepare an affidavit of good faith confirming the proper purpose of the application.
9. Disclose all related proceedings (civil, criminal, or regulatory) in any jurisdiction.
10. Draft the proposed Norwich Pharmacal order, including specific categories of disclosure sought.
11. Prepare protective measures: confidentiality ring membership, redaction proposals, sealed-schedule provisions, and limited-use undertakings.
12. Complete a privacy impact assessment addressing Data Protection Act 2017 requirements.
13. Prepare a pre-action liaison letter to the bank (seeking voluntary disclosure before filing).
14. If voluntary disclosure is refused or impracticable, finalise the application bundle.
15. Determine whether the application should be made with notice or without notice (ex parte).
16. File the application with the Supreme Court of Mauritius.
17. Effect service on the respondent bank in accordance with Supreme Court rules.
18. Where appropriate, notify the Financial Intelligence Unit or the Bank of Mauritius.
19. Attend the hearing with the proposed draft order and all supporting materials.
20. Following the order, monitor bank compliance within the specified timeframe and apply for further directions if necessary.

Applicants may also wish to prepare a short liaison letter for the bank, distinct from the court filing, that sets out the proposed scope of disclosure and invites voluntary compliance within a specified period. This can streamline the process and demonstrate good faith to the court.

How to Get a Norwich Pharmacal Order in Mauritius, Conclusion & Next Steps

The jurisdictional landscape for obtaining a Norwich Pharmacal order in Mauritius is now settled. Following the Privy Council’s decision in Stanford Asset Holdings v AfrAsia [2023] UKPC 35, applicants have a clear path to compel bank disclosure, provided they meet the evidential criteria of a good arguable case, respondent involvement, necessity, proportionality, and proper purpose. Practitioners who prepare thorough application bundles, propose robust protective measures, and anticipate standard bank objections will be well-positioned to secure disclosure efficiently.

For dispute resolution matters in Mauritius, or to find a Mauritius dispute resolution lawyer experienced in bank disclosure and Norwich Pharmacal applications, consult the Global Law Experts directory.

Sources

1. Judicial Committee of the Privy Council, Stanford Asset Holdings Ltd & Anor v AfrAsia Bank Ltd [2023] UKPC 35
2. Bank of Mauritius, Banking Act 2004
3. Banking Act 2004 (official Act text)
4. Data Protection Office Mauritius, Data Protection Act 2017
5. HSF Kramer, Privy Council considers Norwich Pharmacal and Bankers Trust disclosure orders against banks
6. ENSafrica, Mauritius: Privy Council rules that banking confidentiality does not bar Norwich Pharmacal orders